Korecyte Bio is a cell therapy startup based in London, the United Kingdom and was established in 2023/2024. Our mission is to release our next-generation cell therapy tool to render CAR-based therapies much safer and more effective. Our internal developments focus on CAR-T products which can safely target a range of solid cancers and deliver improved outcomes for patients with cancer.
Company Details
- Employees
- 3
- Founded
- 2023
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.korecyte.com
- HQ
- London
Korecyte Bio Questions
Korecyte Bio's website is http://www.korecyte.com
Korecyte Bio's LinkedIn profile is https://uk.linkedin.com/company/korecytebio
Korecyte Bio has
3 employees.
View email and phone details for 3
employees at Korecyte Bio.
Korecyte Bio's industry is
Biotechnology Research
Korecyte Bio's top competitors are
Braincures,
Oncolines B.v.,
Sublin Therapeutics,
Leucid Bio,
Bio2business Ltd,
The Weird Gripper Company,
Chemkas Pharmaceutics,
Carocell Bio,
Glycostem Therapeutics,
Touchlight.
Korecyte Bio's categories are Biotechnology Research
Korecyte Bio's founding year is 2023
